Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure.
Prins PA, Hill MF, Airey D, Nwosu S, Perati PR, Tavori H, F Linton M, Kon V, Fazio S, Sampson UK.
PLoS One. 2014 Jan 23;9(1):e84517. doi: 10.1371/journal.pone.0084517. eCollection 2014.
PMID: 24465413
Augmented cardiac formation of oxidatively-induced carbonylated proteins accompanies the increased functional severity of post-myocardial infarction heart failure in the setting of type 1 diabetes mellitus.
Dennis KE, Hill S, Rose KL, Sampson UK, Hill MF.
Cardiovasc Pathol. 2013 Nov-Dec;22(6):473-80. doi: 10.1016/j.carpath.2013.03.001. Epub 2013 Apr 6.
PMID: 23566587
Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.
Odiete O, Konik EA, Sawyer DB, Hill MF.
Cardiovasc Diabetol. 2013 Mar 27;12:52. doi: 10.1186/1475-2840-12-52.
PMID: 23530877
Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1β improves left ventricular function, gene and protein expression in rats after myocardial infarction.
Hill MF, Patel AV, Murphy A, Smith HM, Galindo CL, Pentassuglia L, Peng X, Lenneman CG, Odiete O, Friedman DB, Kronenberg MW, Zheng S, Zhao Z, Song Y, Harrell FE Jr, Srinivas M, Ganguly A, Iaci J, Parry TJ, Caggiano AO, Sawyer DB.
PLoS One. 2013;8(2):e55741. doi: 10.1371/journal.pone.0055741. Epub 2013 Feb 21.
PMID: 23437060
Neuregulin in cardiovascular development and disease.
Odiete O, Hill MF, Sawyer DB.
Circ Res. 2012 Oct 26;111(10):1376-85. doi: 10.1161/CIRCRESAHA.112.267286. Review.
PMID: 23104879
The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair.
Alfaro MP, Pagni M, Vincent A, Atkinson J, Hill MF, Cates J, Davidson JM, Rottman J, Lee E, Young PP.
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18366-71. doi: 10.1073/pnas.0803437105. Epub 2008 Nov 18.
PMID: 19017790
Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants.
Hill MF.
Curr Cardiol Rev. 2008 Nov;4(4):259-68. doi: 10.2174/157340308786349453.
PMID: 20066133
Dietary supplementation with vitamin E ameliorates cardiac failure in type I diabetic cardiomyopathy by suppressing myocardial generation of 8-iso-prostaglandin F2alpha and oxidized glutathione.
Hamblin M, Smith HM, Hill MF.
J Card Fail. 2007 Dec;13(10):884-92.
PMID: 18068623
Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy.
Hamblin M, Friedman DB, Hill S, Caprioli RM, Smith HM, Hill MF.
J Mol Cell Cardiol. 2007 Apr;42(4):884-95. Epub 2007 Jan 10.
PMID: 17320100
Reduction in oxidative stress and modulation of heart failure subsequent to myocardial infarction in rats.
Hill MF, Palace VP, Kaur K, Kumar D, Khaper N, Singal PK.
Exp Clin Cardiol. 2005 Fall;10(3):146-53.
PMID: 19641679
Greater propensity of diabetic myocardium for oxidative stress after myocardial infarction is associated with the development of heart failure.
Smith HM, Hamblin M, Hill MF.
J Mol Cell Cardiol. 2005 Oct;39(4):657-65.
PMID: 16125723
Antioxidant and oxidative stress changes in experimental cor pulmonale.
Farahmand F, Hill MF, Singal PK.
Mol Cell Biochem. 2004 May;260(1-2):21-9.
PMID: 15228082